SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-012095
Filing Date
2017-12-04
Accepted
2017-12-04 16:23:52
Documents
66
Period of Report
2017-10-31

Document Format Files

Seq Description Document Type Size
1 10-Q opnt1031201710-q.htm 10-Q 665239
2 EXHIBIT 10.6 formisoagreement2017opiant.htm EX-10.6 79740
3 EXHIBIT 10.7 formnqsoagreement2017opian.htm EX-10.7 74884
4 EXHIBIT 10.8 formrestrictedstockagreeme.htm EX-10.8 76749
5 EXHIBIT 31.1 exhibit311.htm EX-31.1 12646
6 EXHIBIT 31.2 exhibit312.htm EX-31.2 12625
7 EXHIBIT 32.1 exhibit321.htm EX-32.1 5806
8 EXHIBIT 32.2 exhibit322.htm EX-32.2 5568
  Complete submission text file 0001628280-17-012095.txt   4757646

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT opnt-20171031.xml EX-101.INS 694216
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opnt-20171031.xsd EX-101.SCH 56001
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opnt-20171031_cal.xml EX-101.CAL 44141
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opnt-20171031_def.xml EX-101.DEF 304449
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opnt-20171031_lab.xml EX-101.LAB 562760
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opnt-20171031_pre.xml EX-101.PRE 398421
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-38193 | Film No.: 171237322
SIC: 1000 Metal Mining
Assistant Director 9